Headquarters
10004 BENTLEY WAY, TAMPA, FL 33626-5141, US
TAMPA, FL, US
ASPIRA THERAPEUTICS, INC
From the company
Aspira Therapeutics is developing Aspirvent, a first-in-class alginate-based intragastric barrier device that forms a coherent gel raft on the gastric surface to physically prevent pulmonary aspiration during anesthesia induction and sedation. The company is prioritizing patients on GLP-1 therapy before expanding into broader pre-operative gastric-content protection.
Products & services offered
Capabilities 4
Materials 4
Classifications
- Materials (4)
- alginate, bicarbonate, calcium, sodium alginate
Facilities
Send your requirements
Quantities, certifications, and timing.